In addition, several vaccines have targeted antigens expressed both on the tumor and endothelial cells and thus inducing a broader and enhanced immune response, for example targeting survivin (75) (110–123) (Supplementary Table 1). The gene discussed is BIRC5; the disease is neoplasm.